Mithramycin for Lung, Esophagus, and Other Chest Cancers
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Esophageal Cancer|Mesothelioma|Gastrointestinal Neoplasms|Breast Cancer
Interventions: DRUG: Mithramycin
Sponsor: National Cancer Institute (NCI)